Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease.

[1]  A. Melms,et al.  Thymus and myasthenia gravis: antigen processing in the human thymus and the consequences for the generation of autoreactive T cells , 2006, Acta neurologica Scandinavica. Supplementum.

[2]  K. Kondo,et al.  WHO histologic classification is a prognostic indicator in thymoma. , 2004, The Annals of thoracic surgery.

[3]  A. Shamseddine,et al.  Transfusion‐associated GVHD: 10 years’ experience at the American University of Beirut—Medical Center , 2003, Transfusion.

[4]  E. Sercarz,et al.  MHC-guided processing: binding of large antigen fragments , 2003, Nature Reviews Immunology.

[5]  R. Pfeiffer,et al.  Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies , 2003, International journal of cancer.

[6]  F. A. Bhatti,et al.  Transfusion associated graft versus host disease. , 2003, Journal of Ayub Medical College, Abbottabad : JAMC.

[7]  S. Sleijfer,et al.  Full-blown graft-versus-host disease presenting with skin manifestations, jaundice and diarrhoea: an unusual paraneoplastic phenomenon of a thymoma. , 2003, European journal of gastroenterology & hepatology.

[8]  D. Bostwick,et al.  CASE REPORT: Graft-Versus-Host-Like Colitis and Malignant Thymoma , 2002, Digestive Diseases and Sciences.

[9]  M. Edwards,et al.  Graft-versus-host disease-type colitis: an unusual association of malignant thymoma. , 2002, The Annals of thoracic surgery.

[10]  H. Matsuda,et al.  The World Health Organization histologic classification system reflects the oncologic behavior of thymoma , 2002, Cancer.

[11]  E Lanino,et al.  Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. , 2001, Blood.

[12]  P. Lara.  Malignant thymoma: current status and future directions. , 2000, Cancer treatment reviews.

[13]  K. Whaley,et al.  Thymoma‐associated cutaneous graft‐versus‐host‐like reaction , 1997, Clinical and experimental dermatology.

[14]  E. Sercarz,et al.  Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues , 1996, The Journal of experimental medicine.

[15]  E. Sercarz,et al.  Hindrance of binding to class II major histocompatibility complex molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Lazenby,et al.  Graft-versus-host-like colitis associated with malignant thymoma. , 1995, The American journal of surgical pathology.

[17]  R. Livingston,et al.  Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  E. Sercarz,et al.  How some T cells escape tolerance induction , 1989, Nature.

[19]  E. Rosenow,et al.  Disorders of the thymus. A review. , 1984, Archives of internal medicine.

[20]  Y. Monden,et al.  Follow‐up study of thymomas with special reference to their clinical stages , 1981, Cancer.

[21]  C. Y. Wang,et al.  Graft-versus-Host disease-like syndrome in malignant thymoma. , 2000, Scandinavian journal of gastroenterology.

[22]  A. Miller,et al.  Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.

[23]  R. Good.  Agammaglobulinemia-a provocative experiment of nature , 1954 .